Skip to content

YVOMEDICAL

Active Private limited companyfounded 2020active for 6 yearsAntoine Depagelaan 9, 1000 BrusselsKBO/BCE: BE 0747.944.036

Annual accounts 2025

micro format, filed on 24-08-2026, 24 days late
€362,152
▼ 3.3%
€198,768
▲ 14.4%
€143,242
▼ 5.6%
-€85,675
▲ €192,474
34.8%
▲ 25.6 percentage points
0.72
▲ 0.24

Turnover is estimated at about €550,000, probably between €480,000 and €760,000. The micro format does not state turnover.

Balance sheet

balance sheet total €572,729 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

34.8%

Higher than 29% of the 21,385 companies filing micro accounts in human health (NACE 86) in 2025.

0.72

Higher than 10% of the 20,936 companies filing micro accounts in human health (NACE 86) in 2025.

25.0%

Higher than 58% of the 21,236 companies filing micro accounts in human health (NACE 86) in 2025.

YVOMEDICAL Middle half of the sector 80% of the sector Micro accounts in human health (NACE 86)

Net result: top quarter · Equity: middle half · Balance sheet total: middle half · Working capital: bottom quarter

Staff

€57,345

Staff costs divided by the average number of full-time equivalents.

employees who joined employees who left

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend2025202420232022202119 months
303,307276,115232,089-227,104323,286
247,782254,099226,631-234,380263,476
100,55701,0764,992811,380
-1,83624,656-111,499113,027-
-85,675-278,150-441,544-268,860-103,574
34.8%9.2%-15.5%-26.1%14.1%
0.720.480.270.510.65
1.879.89--6.11
71.9%270.8%--89.9%
25.0%24.9%19.9%-40.4%12.6%
26.5712.7345.36-32.5325.92

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend2025202420232022202119 months
Balance sheet: assets
20/58 572,729609,871619,011838,491848,702
21/28 348,366352,348454,788556,151655,244
21 249,589349,589449,589549,589649,837
22/27 98,7772,7595,1996,5625,407
23 4779691,4611,9532,446
24 98,2991,7903,7384,6082,962
29/58 224,364257,523164,223282,341193,457
40/41 6,934-29,36447,75518,049
40 ---387387
41 6,934-29,36447,36717,662
54/58 29,54031,3766,720118,2195,192
490/1 187,890226,147128,140116,367170,216
Balance sheet: equity and liabilities
10/49 572,729609,871619,011838,491848,702
10/15 199,25356,011-95,649-219,125119,341
10/11 12,00012,00012,00012,00012,000
13 187,253107,341107,341107,341107,341
133 187,253107,341107,341107,341107,341
14 --63,330-214,990-338,466-
16 ---234,754-
160/5 ---234,754-
164/5 ---234,754-
17/49 373,476553,860714,660822,862729,361
17 63,356-108,893271,662432,329
170/4 63,356-108,893271,662432,329
42/48 310,039535,672605,767551,201297,032
42 70,731123,472176,532199,446172,372
44 40,49575,36427,36354,26923,610
440/4 40,49575,36427,36354,26923,610
45 26,49222,24323,09421,80217,305
450/3 9,6576,8586,5006,5006,500
454/9 16,83415,38516,59415,30210,805
47/48 172,321314,593378,778275,68483,745
492/3 8118,188---
Income statement
9900 362,152374,554577,924115,701423,611
62 57,34598,439110,858105,48399,479
630 104,539102,440103,155104,086156,135
635/8 ---234,754-
640/8 1,500-2231,048846
66A --234,7541,520-
9901 198,768173,675128,934-331,189167,150
75/76B 734003
75 734003
65/66B 11,41321,6915,1176,98212,474
65 11,41321,6915,1176,98212,474
9903 187,361152,018123,818-338,171154,679
67/77 44,11935834129547,338
9904 143,242151,660123,476-338,466107,341
9905 143,242151,660123,476-338,466107,341
Appropriation of the result
9906 79,912-63,330-214,990-338,466107,341
14P -63,330-214,990-338,466--
691/2 79,912---107,341
6921 79,912---107,341
Social balance sheet
9087 11111
Hours worked1013 --1,8081,80819,304
Document PDFPDFPDFPDFPDF

The full notes are in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 24-08-2026.

Filings

each dot is a set of accounts, on the day it reached the National Bank

The accounts were filed on 24-08-2026. The deadline was 31-07-2026, 7 months after the close on 31-12-2025 (article 3:10 of the Companies and Associations Code). Source: NBB, 2026-00425076.

Financial year Type Filed Reference Document
31-12-2025 micro format 24-08-2026 2026-00425076 PDF
31-12-2024 micro format 17-09-2025 2025-00500164 PDF
31-12-2023 micro format 06-10-2024 2024-00498249 PDF
31-12-2022 micro format 29-08-2023 2023-00409263 PDF
31-12-2021 micro format 26-08-2022 2022-20324646 PDF

Social balance sheet

Item31-12-202531-12-202431-12-202331-12-202231-12-2021
Employees at the balance-sheet date--111
full-time--111
part-time--0--
in full-time equivalents0.5--11
0.50.5111
On a permanent contract11111
Joined----1
Left----0

Source: social balance sheet in the 2021 to 2025 annual accounts

Overdue debts

tax and social security
Item20252024202320222021
Overdue tax debts---€6,500€6,500
Overdue social security (RSZ) debts----€10,805

Source: notes to the 2021 to 2025 annual accounts (statement of debts)

Investments

fixed assets acquired
Item20252024202320222021
Tangible fixed assets€100,557-€1,076€4,992€10,380
Intangible fixed assets----€801,000
€104,539€102,440€103,155€104,086€156,135

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on YVOMEDICAL

The operating result for 2025 is 14% higher than in 2024 and the highest since 2022. It is the third rise in a row.

Debt's share of the balance-sheet total falls from 90.8% to 65.2%. Equity is higher and debt is lower.

Next steps